-
1 month ago | 
dermatologytimes.com | Emma Andrus |Maddi Hebebrand
PublicationArticleMarch 18, 2025Dermatology TimesDermatology Times, March 2025 (Vol. 46. No. 03)Volume46 Issue 03Author(s):,Join Dermatology Times in celebrating the women who make this field shine through their patient interactions, clinical insights, and research. As treatment guidelines, medical treatments, and patient perspectives change, so too has the demographic makeup of the dermatology specialty.
-
1 month ago | 
dermatologytimes.com | Emma Andrus |Maddi Hebebrand
The US FDA recently issued an alert regarding potential benzene contamination in benzoyl peroxide (BPO)-containing products.1 The agency conducted independent testing of 95 acne treatment products after receiving third-party reports raising concerns about elevated benzene levels. The FDA's findings indicate that more than 90% of the tested products had either undetectable or extremely low levels of benzene.
-
1 month ago | 
dermatologytimes.com | Maddi Hebebrand |Emma Andrus
Author(s):,Published in JID, the paper analyzes the FDA’s FAERS database and cases of neoplasms such as skin cancer, breast cancer, and other malignancies.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand |Naiem T. Issa
A patient-centered approach ensures that hair loss treatments align with individual goals and medical history.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand |Philip Mease
Recently, Philip Mease, MD, director of rheumatology research at Providence Swedish Medical Center in Seattle, Washington, led a comprehensive qualitative study aimed at understanding the concerns and priorities of psoriatic arthritis (PsA) patients. "What we did in this study was to conduct a series of 3PsA patient focus groups in Seattle, Cleveland, and Washington, DC," Mease explained in an interview with Dermatology Times.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand
In a recent interview with Dermatology Times, James Del Rosso, DO, a dermatologist based in Las Vegas, Nevada, shared insights on Hailey-Hailey disease he shared during his presentation at Winter Clinical Miami titled, “What’s New in the Medicine Chest?” Known for his extensive work in clinical dermatology, research, and educational initiatives, Del Rosso provided valuable information about this rare and challenging skin condition.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand
In a recent presentation at Winter Clinical Miami, Jim Del Rosso, DO, a dermatologist and clinical researcher based in Las Vegas, Nevada, shed light on the evolving landscape of granuloma annulare (GA), a condition that, while commonly encountered in dermatological practice, presents significant therapeutic challenges.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand
Skin hydration and moisturization are crucial for maintaining the skin’s barrier function and aesthetic properties.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand
In a recent interview with Dermatology Times, Jim Del Rosso, DO, a dermatologist based in Las Vegas, Nevada, provided key insights into the complex relationship between atopic dermatitis (AD) and ocular complications that he presented at Winter Clinical Miami. Drawing from his clinical experience and involvement in research, Del Rosso emphasizes the importance of addressing ocular comorbidities in patients with AD, particularly when managing the adverse effects of advanced biologic therapies.
-
2 months ago | 
dermatologytimes.com | Maddi Hebebrand
In an insightful presentation at the Winter Clinical Miami 2025, James Del Rosso, DO, a dermatologist based in Las Vegas, Nevada, shared groundbreaking insights on a novel approach to treating mild to moderate acne. Del Rosso, who runs a clinical dermatology research center, highlighted the results of a recent case series published in the Journal of Clinical and Aesthetic Dermatology by Emmy Graber’s group out of Boston.
